Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study

go back to reference Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002, 359: 2140-2144. 10.1016/S0140-6736(02)09089-X.CrossRefPubMed Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002, 359: 2140-2144. 10.1016/S0140-6736(02)09089-X.CrossRefPubMed

go back to reference Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L: Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004, 25: 1990-1997. 10.1016/j.ehj.2004.09.021.CrossRefPubMed Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L: Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004, 25: 1990-1997. 10.1016/j.ehj.2004.09.021.CrossRefPubMed

go back to reference Ryden L, Standl E, Bartnik M, Van den BG, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007, 28: 88-136. 10.1093/eurheartj/ehm124.CrossRefPubMed Ryden L, Standl E, Bartnik M, Van den BG, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007, 28: 88-136. 10.1093/eurheartj/ehm124.CrossRefPubMed

go back to reference Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO: Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol. 2009, 8: 6-10.1186/1475-2840-8-6.PubMedCentralCrossRefPubMed Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO: Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol. 2009, 8: 6-10.1186/1475-2840-8-6.PubMedCentralCrossRefPubMed

go back to reference Libby P: Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006, 83: 456S-460S.PubMed Libby P: Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006, 83: 456S-460S.PubMed

go back to reference Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002, 287: 2570-2581. 10.1001/jama.287.19.2570.CrossRefPubMed Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002, 287: 2570-2581. 10.1001/jama.287.19.2570.CrossRefPubMed

go back to reference Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002, 51: 1596-1600. 10.2337/diabetes.51.5.1596.CrossRefPubMed Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002, 51: 1596-1600. 10.2337/diabetes.51.5.1596.CrossRefPubMed

go back to reference Ziegler D: Type 2 diabetes as an inflammatory cardiovascular disorder. Curr Mol Med. 2005, 5: 309-322. 10.2174/1566524053766095.CrossRefPubMed Ziegler D: Type 2 diabetes as an inflammatory cardiovascular disorder. Curr Mol Med. 2005, 5: 309-322. 10.2174/1566524053766095.CrossRefPubMed

go back to reference Definition, Diagnosis and Classification of Diabetes Mellitus and its Complication. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. [http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf] Definition, Diagnosis and Classification of Diabetes Mellitus and its Complication. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. [http://​www.​staff.​ncl.​ac.​uk/​philip.​home/​who_​dmg.​pdf]

go back to reference Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF Consultation. [http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf] Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF Consultation. [http://​www.​who.​int/​diabetes/​publications/​Definition%20​and%20​diagnosis%20​of%20​diabetes_​new.​pdf]

go back to reference Gibbons RJ, Miller TD, Christian TF: Infarct size measured by single photon emission computed tomographic imaging with (99 m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. Circulation. 2000, 101: 101-108.CrossRefPubMed Gibbons RJ, Miller TD, Christian TF: Infarct size measured by single photon emission computed tomographic imaging with (99 m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. Circulation. 2000, 101: 101-108.CrossRefPubMed

go back to reference Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic research. Principles and quantitative methods. 1982, New York: Van Nostrand Reinhold Company Inc Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic research. Principles and quantitative methods. 1982, New York: Van Nostrand Reinhold Company Inc

go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370: 1453-1457. 10.1016/S0140-6736(07)61602-X.CrossRefPubMed von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370: 1453-1457. 10.1016/S0140-6736(07)61602-X.CrossRefPubMed

go back to reference Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002, 106: 2067-2072. 10.1161/01.CIR.0000034509.14906.AE.CrossRefPubMed Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002, 106: 2067-2072. 10.1161/01.CIR.0000034509.14906.AE.CrossRefPubMed

go back to reference Norhammar AM, Ryden L, Malmberg K: Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care. 1999, 22: 1827-1831. 10.2337/diacare.22.11.1827.CrossRefPubMed Norhammar AM, Ryden L, Malmberg K: Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care. 1999, 22: 1827-1831. 10.2337/diacare.22.11.1827.CrossRefPubMed

go back to reference Gasior M, Pres D, Stasik-Pres G, Lech P, Gierlotka M, Hawranek M, Wilczek K, Szygula-Jurkiewicz B, Lekston A, Kalarus Z, Strojek K, Gumprecht J, Polonski L: Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J. 2008, 15: 422-430.PubMed Gasior M, Pres D, Stasik-Pres G, Lech P, Gierlotka M, Hawranek M, Wilczek K, Szygula-Jurkiewicz B, Lekston A, Kalarus Z, Strojek K, Gumprecht J, Polonski L: Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J. 2008, 15: 422-430.PubMed

go back to reference Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9.CrossRefPubMed Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9.CrossRefPubMed

go back to reference Solheim S, Grogaard HK, Hoffmann P, Arnesen H, Seljeflot I: Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris. Scand J Clin Lab Invest. 2008, 68: 555-562. 10.1080/00365510701884584.CrossRefPubMed Solheim S, Grogaard HK, Hoffmann P, Arnesen H, Seljeflot I: Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris. Scand J Clin Lab Invest. 2008, 68: 555-562. 10.1080/00365510701884584.CrossRefPubMed

go back to reference Karpinski L, Plaksej R, Derzhko R, Orda A, Witkowska M: Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up. Pol Arch Med Wewn. 2009, 119: 115-121.PubMed Karpinski L, Plaksej R, Derzhko R, Orda A, Witkowska M: Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up. Pol Arch Med Wewn. 2009, 119: 115-121.PubMed

go back to reference strom-Olsson K, Hedstrom E, Hulten LM, Wiklund O, Arheden H, Ohlin AK, Gottsater A, Ohlin H: Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction. J Invasive Cardiol. 2007, 19: 452-456. strom-Olsson K, Hedstrom E, Hulten LM, Wiklund O, Arheden H, Ohlin AK, Gottsater A, Ohlin H: Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction. J Invasive Cardiol. 2007, 19: 452-456.

go back to reference Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001, 286: 327-334. 10.1001/jama.286.3.327.CrossRefPubMed Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001, 286: 327-334. 10.1001/jama.286.3.327.CrossRefPubMed

go back to reference Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, Sasayama S: Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol. 1997, 29: 419-423. 10.1006/jmcc.1996.0285.CrossRefPubMed Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, Sasayama S: Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol. 1997, 29: 419-423. 10.1006/jmcc.1996.0285.CrossRefPubMed

go back to reference Mine S, Okada Y, Tanikawa T, Kawahara C, Tabata T, Tanaka Y: Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem Biophys Res Commun. 2006, 344: 780-785. 10.1016/j.bbrc.2006.03.197.CrossRefPubMed Mine S, Okada Y, Tanikawa T, Kawahara C, Tabata T, Tanaka Y: Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem Biophys Res Commun. 2006, 344: 780-785. 10.1016/j.bbrc.2006.03.197.CrossRefPubMed

go back to reference Dragomir E, Simionescu M: Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem. 2006, 112: 239-244. 10.1080/13813450601094672.CrossRefPubMed Dragomir E, Simionescu M: Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem. 2006, 112: 239-244. 10.1080/13813450601094672.CrossRefPubMed

go back to reference Park KS, Ahn KJ, Kim BJ, Kim HJ, Yoo SM, Kim JY, Lee KH, Baik HW, Lee SK: Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women. Clin Chim Acta. 2009, 403: 92-96. 10.1016/j.cca.2009.01.025.CrossRefPubMed Park KS, Ahn KJ, Kim BJ, Kim HJ, Yoo SM, Kim JY, Lee KH, Baik HW, Lee SK: Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women. Clin Chim Acta. 2009, 403: 92-96. 10.1016/j.cca.2009.01.025.CrossRefPubMed

go back to reference Braunersreuther V, Mach F, Steffens S: The specific role of chemokines in atherosclerosis. Thromb Haemost. 2007, 97: 714-721.PubMed Braunersreuther V, Mach F, Steffens S: The specific role of chemokines in atherosclerosis. Thromb Haemost. 2007, 97: 714-721.PubMed

go back to reference Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Szelachowska M, Kinalska I: Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol. 2003, 2: 5-10.1186/1475-2840-2-5.PubMedCentralCrossRefPubMed Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Szelachowska M, Kinalska I: Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol. 2003, 2: 5-10.1186/1475-2840-2-5.PubMedCentralCrossRefPubMed

go back to reference Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C: Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes. 2005, 54: 2932-2938. 10.2337/diabetes.54.10.2932.CrossRefPubMed Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C: Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes. 2005, 54: 2932-2938. 10.2337/diabetes.54.10.2932.CrossRefPubMed

go back to reference Derosa G, Cicero AF, Scalise F, Avanzini MA, Tinelli C, Peros E, Fogari E, D'Angelo A: Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months. Endothelium. 2007, 14: 175-183. 10.1080/10623320601177064.CrossRefPubMed Derosa G, Cicero AF, Scalise F, Avanzini MA, Tinelli C, Peros E, Fogari E, D'Angelo A: Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months. Endothelium. 2007, 14: 175-183. 10.1080/10623320601177064.CrossRefPubMed

go back to reference Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1599.CrossRefPubMed Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1599.CrossRefPubMed